← All organizations

AmDerma

For profit

Also known as: AmDerma | AmDerma Pharmaceuticals, LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 6, 2017

Acquired by Amneal Pharmaceuticals on Dec 20, 2020

Timeline

2010s

Jun 1, 2010
AmDerma— Founded

2020s

Dec 20, 2020
Amneal Pharmaceuticals— Acquired By

Drugs by trial phase (2 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

econazole

Phase 2 (1 own, 0 via acquisition)

Atrosimab

Indications

Studied for

Recent trials (10)

NCT03210740Lead sponsorPhase 2Jun 6, 2017
NCT03005964Lead sponsorPhase 2Dec 1, 2016
NCT01938599Lead sponsorPhase 2Aug 1, 2013
NCT01696799Lead sponsorPhase 2Sep 1, 2011
NCT01696799CollaboratorPhase 2Sep 1, 2011
NCT01358240CollaboratorPhase 3Jun 1, 2011
NCT01358240Lead sponsorPhase 3Jun 1, 2011
NCT01353976CollaboratorPhase 3May 1, 2011
NCT01353976Lead sponsorPhase 3May 1, 2011
NCT00768599Lead sponsorPhase 2Mar 1, 2008

Details

Founded: Bridgewater, NJ, US Jun 1, 2010
Last known activity: Jun 6, 2017